PMID- 36100140 OWN - NLM STAT- MEDLINE DCOM- 20221115 LR - 20221115 IS - 1532-2939 (Electronic) IS - 0195-6701 (Print) IS - 0195-6701 (Linking) VI - 130 DP - 2022 Dec TI - Efficiency and sensitivity optimization of a protocol to quantify indoor airborne SARS-CoV-2 levels. PG - 44-51 LID - S0195-6701(22)00274-2 [pii] LID - 10.1016/j.jhin.2022.08.011 [doi] AB - BACKGROUND: Development of methodologies to quantify airborne micro-organisms is needed for the prevention and control of infections. It is difficult to conclude which is the most efficient and sensitive strategy to assess airborne SARS-CoV-2 RNA levels due to the disparity of results reported in clinical settings. AIM: To improve our previously reported protocol of measuring SARS-CoV-2 RNA levels, which was based on bioaerosol collection with a liquid impinger and RNA quantification with droplet digital polymerase chain reaction (ddPCR). METHODS: Air samples were collected in COVID-19 patient rooms to assess efficiency and/or sensitivity of different air samplers, liquid collection media, and reverse transcriptases (RT). FINDINGS: Mineral oil retains airborne RNA better than does hydrophilic media without impairing integrity. SARS-CoV-2 ORF1ab target was detected in 80% of the air samples using BioSampler with mineral oil. No significant differences in effectiveness were obtained with MD8 sampler equipped with gelatine membrane filters, but the SARS-CoV-2 copies/m(3) air obtained with the latter were lower (28.4 +/- 6.1 vs 9 +/- 1.7). SuperScript II RT allows the detection of a single SARS-CoV-2 genome RNA molecule by ddPCR with high efficiency. This was the only RT that allowed the detection of SARS-CoV-2 N1 target in air samples. CONCLUSION: The collection efficiency and detection sensivity of a protocol to quantify SARS-CoV-2 RNA levels in indoor air has been improved in the present study. Such optimization is important to improve our understanding of the microbiological safety of indoor air. CI - Copyright (c) 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved. FAU - Truyols-Vives, J AU - Truyols-Vives J AD - Molecular Biology and One Health Research Group (MolONE), Universitat de les Illes Balears (UIB), Palma, Spain. FAU - Stiliyanov-Atanasov, K AU - Stiliyanov-Atanasov K AD - Molecular Biology and One Health Research Group (MolONE), Universitat de les Illes Balears (UIB), Palma, Spain. FAU - Sala-Llinas, E AU - Sala-Llinas E AD - Molecular Biology and One Health Research Group (MolONE), Universitat de les Illes Balears (UIB), Palma, Spain; Health Research Institute of the Balearic Islands (IdISBa), Balearic Islands, Spain; Department of Pulmonary Medicine, Hospital Universitari Son Espases (HUSE), Balearic Islands, Spain; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain. FAU - Toledo-Pons, N AU - Toledo-Pons N AD - Health Research Institute of the Balearic Islands (IdISBa), Balearic Islands, Spain; Department of Pulmonary Medicine, Hospital Universitari Son Espases (HUSE), Balearic Islands, Spain. FAU - Baldovi, H G AU - Baldovi HG AD - Department of Chemistry, Universitat Politecnica de Valencia, Valencia, Spain. FAU - Mercader-Barcelo, J AU - Mercader-Barcelo J AD - Molecular Biology and One Health Research Group (MolONE), Universitat de les Illes Balears (UIB), Palma, Spain; Health Research Institute of the Balearic Islands (IdISBa), Balearic Islands, Spain. Electronic address: Josep.mercader@uib.es. LA - eng PT - Journal Article DEP - 20220912 PL - England TA - J Hosp Infect JT - The Journal of hospital infection JID - 8007166 RN - 0 (RNA, Viral) RN - 8020-83-5 (Mineral Oil) SB - IM MH - Humans MH - *SARS-CoV-2/genetics MH - *COVID-19/prevention & control MH - RNA, Viral/genetics MH - Mineral Oil PMC - PMC9465472 OTO - NOTNLM OT - Bioaerosol OT - Droplet digital PCR OT - Impinger OT - SARS-CoV-2 EDAT- 2022/09/14 06:00 MHDA- 2022/11/16 06:00 PMCR- 2022/09/12 CRDT- 2022/09/13 19:25 PHST- 2022/07/29 00:00 [received] PHST- 2022/08/24 00:00 [revised] PHST- 2022/08/26 00:00 [accepted] PHST- 2022/09/14 06:00 [pubmed] PHST- 2022/11/16 06:00 [medline] PHST- 2022/09/13 19:25 [entrez] PHST- 2022/09/12 00:00 [pmc-release] AID - S0195-6701(22)00274-2 [pii] AID - 10.1016/j.jhin.2022.08.011 [doi] PST - ppublish SO - J Hosp Infect. 2022 Dec;130:44-51. doi: 10.1016/j.jhin.2022.08.011. Epub 2022 Sep 12.